Related Experiment Video
Updated: Jun 21, 2026
06:38
The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
Published on: December 19, 2025
Invited article: searching for oracles? Blood biomarkers in acute stroke
C Foerch1, J Montaner, K L Furie
1Neuroprotection Research Laboratory, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. foerch@em.uni-frankfurt.de
Neurology
|August 5, 2009
Summary
Blood biomarkers offer a new way to understand stroke. While many candidates show promise for diagnosis and treatment, further clinical trials are needed to confirm their usefulness in stroke care.
Area of Science:
- Neurology
- Biochemistry
- Medical Diagnostics
Background:
- Stroke diagnosis and management rely heavily on clinical examination and neuroimaging.
- Understanding the underlying pathophysiology of stroke is crucial for improving patient outcomes.
- Biomarkers in blood present a potential new avenue for stroke assessment.
Purpose of the Study:
- To review the current progress of blood biomarkers in stroke research.
- To assess the potential of biomarkers in enhancing stroke diagnosis.
- To evaluate the role of biomarkers in patient triage for thrombolytic therapy and predicting malignant infarction.
Main Methods:
- Literature review of emerging data on blood biomarkers for stroke.
- Assessment of biomarker potential against established diagnostic and prognostic tools.
- Analysis of molecular candidates identified in relation to neurovascular injury cascades.
Main Results:
- Numerous molecular candidates have been identified as potential biomarkers for stroke.
- These candidates show promise in reflecting the known neurovascular injury pathways.
- Quantitative validation of clinical utility for these biomarkers is still pending.
Conclusions:
- Blood biomarkers may offer valuable insights into stroke pathophysiology.
- Further large-scale clinical trials are essential to establish biomarker sensitivity and specificity.
- Routine clinical utility of biomarkers in stroke management requires rigorous validation.
Related Concept Videos
01:17Hemorrhagic Stroke l: Introduction
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...